Jonathan Allan

Insider Reports History

Entity
Individual
Location
C/O Stoke Therapeutics, Inc., 45 Wiggins Avenue, Bedford, MA
Signature
/s/ Jonathan Allan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Allan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Stoke Therapeutics, Inc. GENERAL COUNSEL & CORP SEC Restricted Stock Units 24K $379K $15.78 Mar 27, 2024 Direct
Stoke Therapeutics, Inc. GENERAL COUNSEL & CORP SEC Common Stock 2.6K $39.1K $15.04 May 20, 2024 Direct
Stoke Therapeutics, Inc. GENERAL COUNSEL & CORP SEC Stock Option (Right to Buy) 25.8K May 20, 2024 Direct

Insider Reports Filed by Jonathan Allan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
STOK Stoke Therapeutics, Inc. May 20, 2024 3 -$68.5K 4 May 22, 2024 GENERAL COUNSEL & CORP SEC
STOK Stoke Therapeutics, Inc. Mar 28, 2024 2 -$67.7K 4 Apr 1, 2024 GENERAL COUNSEL & CORP SEC
STOK Stoke Therapeutics, Inc. Mar 27, 2024 2 $0 4 Jun 7, 2024 GENERAL COUNSEL & CORP SEC
STOK Stoke Therapeutics, Inc. Mar 15, 2024 3 -$14.3K 4 Mar 19, 2024 GENERAL COUNSEL & CORP SEC
STOK Stoke Therapeutics, Inc. Dec 1, 2023 3 $0 4 Dec 5, 2023 General Counsel & Corp Sec
STOK Stoke Therapeutics, Inc. Jun 21, 2023 1 -$26.3K 4 Jun 23, 2023 General Counsel & Corp Sec
STOK Stoke Therapeutics, Inc. Mar 15, 2023 2 $0 4 Mar 17, 2023 General Counsel & Corp Sec
STOK Stoke Therapeutics, Inc. Mar 15, 2023 0 $0 3 Mar 17, 2023 General Counsel & Corp Sec